Log in to your Inderes Free account to see all free content on this page.
Hamlet BioPharma
7.13 SEK
+2.15 %
Less than 1K followers
HAMLET B
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Hamlet BioPharma
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 6.50 | 6.50 | 7.74 | 3.75 | 2.69 | 4.14 | 4.13 |
| Shares | 101.6 | 106.4 | 106.4 | 114.9 | 116.4 | 167.8 | 177.7 |
| Market cap | 660.1 | 691.0 | 823.1 | 431.1 | 313.7 | 694.5 | 733.0 |
| Enterprise value | 649.5 | 677.7 | 815.7 | 391.5 | 295.3 | 671.5 | 722.2 |
| EV/S | - | - | - | - | - | - | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| EV/EBIT | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 82.21 | 65.96 | 298.89 | 11.34 | 14.63 | 10.37 | 17.96 |
| P/S | - | - | - | - | - | - | - |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 71.1 % | 72.0 % | 21.6 % | 91.1 % | 74.0 % | 94.2 % | 84.9 % |
| Gearing ratio | - | - | - | - | - | - | - |
Login required
This content is only available for logged in users